BRIEF-Qualigen Therapeutics - Withdrawn EUA Application For FastPack SARS-CoV-2 IgG Diagnostic Test For COVID-19 Antibodies

Reuters · 04/09/2021 21:41
BRIEF-Qualigen Therapeutics - Withdrawn EUA Application For FastPack SARS-CoV-2 IgG Diagnostic Test For COVID-19 Antibodies

- Qualigen Therapeutics Inc QLGN.O:

  • QUALIGEN THERAPEUTICS - WITHDRAWN EUA APPLICATION SUBMITTED TO FDA IN JUNE 2020 FOR FASTPACK SARS-COV-2 IGG DIAGNOSTIC TEST FOR COVID-19 ANTIBODIES

  • QUALIGEN THERAPEUTICS INC - CO BELIEVES THERE IS NO LONGER A VIABLE BUSINESS CASE FOR SCALE-UP OF TEST

Source text: (https://bit.ly/3dIJFLS)

Further company coverage: QLGN.O


((Reuters.Briefs@thomsonreuters.com;))